Last Price
0.09
Today's Change
+0.001 (1.12%)
Day's Change
0.087 - 0.09
Trading Volume
273,281
Market Cap
40 Million
Shares Outstanding
447 Million
Avg Volume
481,116
Avg Price (50 Days)
0.09
Avg Price (200 Days)
0.17
PE Ratio
-3.00
EPS
-0.03
Earnings Announcement
04-Mar-2026
Previous Close
0.09
Open
0.09
Day's Range
0.087 - 0.09
Year Range
0.082 - 0.325
Trading Volume
273,281
1 Day Change
1.12%
5 Day Change
-4.26%
1 Month Change
-2.17%
3 Month Change
-25.00%
6 Month Change
-52.63%
Ytd Change
-53.85%
1 Year Change
-48.57%
3 Year Change
-54.59%
5 Year Change
-72.75%
10 Year Change
-72.75%
Max Change
-72.75%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; Databank, for discovery of therapeutic leads, consumer health innovations, and diagnostic biomarkers; and data-driven therapeutics platform that develops novel monoclonal microbial cell therapies for inflammatory bowel disease, cancer immunotherapy, and autoimmune diseases. The company was incorporated in 2017 and is based in Brisbane, Australia.
{uid}
{comment}
Just now